Title:
Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database
Date:

February 5, 2020

Author:
Assi, Mukherjee, Machiorlatti, Vesely, Pareek & Hatoum
Description:
Journal article published in Anticancer Research

This publication retrospectively analyzes the clinicopathological factors and treatments affecting overall survival in FLC. Using the National Cancer Database, it identified 496 patients diagnosed with FLC between 2004 and 2015. Of those patients, resection was performed on 254 (51.2%), liver-directed therapy on 13 (2.6%), and liver transplantation on 15 (3.0%) patients. Median overall survival times by disease stage were 142.1, 87.2, 32.3, and 14.1 months for stages 1, 2, 3, and 4, respectively.

The full article can be read or downloaded below: